|
|
Identification |
|
Name |
|
Pralsetinib |
|
Synonyms |
|
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide |
|
|
Molecular Structure |
|
![CAS # 2097132-94-8, Pralsetinib, N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide](/structures/2097132-94-8.gif) |
|
|
Molecular Weight |
|
533.60 |
|
CAS Registry Number |
|
2097132-94-8 |
|
EINECS |
|
861-037-3 |
|
SMILES |
|
CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC |
| |
|
Safety Data |
|
|
Hazard Symbols |
|
GHS07 Warning Details |
|
Hazard Statements |
|
H302-H315-H319-H335 Details |
|
Precautionary Statements |
|
P261-P280-P301+P312-P302+P352-P305+P351+P338 Details |
|
SDS |
|
Available |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
